BioLineRx (BLRX) Issued US Patent Covering BL-8040 to Obtain Stem Cells – StreetInsider.com (subscription)
BioLineRx (BLRX) Issued US Patent Covering BL-8040 to Obtain Stem CellsStreetInsider.com (subscription)BioLineRx (Nasdaq: BLRX) announced that an Issue Notification has been received from the United States Patent and Trademark Office (USPTO) for US Patent No. 8,455,450, which claims the use of BL-8040’s composition for obtaining hematopoietic … and more …read more &nbs… Continue reading
